Insight Molecular Diagnostics Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2016 | $4.6M | $14.4M | $10.2M |
| FY2017 | $5.8M | $10.2M | $7.6M |
| FY2018 | $6.1M | $9.5M | $8.0M |
| FY2019 | $9.0M | $39.9M | $22.1M |
| FY2020 | $21.9M | $55.4M | $7.1M |
| FY2021 | $94.3M | $159.6M | $32.9M |
| FY2022 | $60.5M | $100.1M | $20.0M |
| FY2023 | $49.3M | $74.9M | $9.4M |
| FY2024 | $47.4M | $35.1M | $8.6M |
| FY2025 | $57.2M | $25.8M | $11.6M |